Steglatro

Description

Steglatro is an oral drug from MSD based on the active substance Ertugliflozin, which helps control blood sugar levels in patients with type 2 diabetes.

It can be used as monotherapy or combined with insulin, metformin, if these drugs themselves do not have the desired effect.

Active ingredient: Ertugliflozin

Prescription medicine